Relay Therapeutics, Inc. Ratios

Ratios Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin 129,836.21%-63.41%-12,012.94%-21,034.69%-1,338.59%-3,374.86%
EBIT Margin 144,910.34%-67.51%-12,040.21%-21,670.89%-1,460.11%-3,722.07%
EBITDA Margin 129,275.86%-63.73%-12,050.97%-21,711.88%-1,298.63%-3,382.66%
Operating Margin 144,910.34%-67.51%-12,040.21%-21,670.89%-1,460.11%-3,722.07%
Net Margin 129,836.21%-278.51%-12,012.94%-21,036.13%-1,338.59%-3,374.86%
FCF Margin 127,818.97%-126.33%-2,571.05%-17,273.86%-1,191.74%-2,509.49%
Efficiency
Assets Average 904.14M1,054.11M971.88M857.64M
Equity Average 830.55M924.01M851.11M764.90M
Invested Capital 763.29M897.81M950.22M752.00M777.79M
Asset Utilization Ratio 0.000.000.030.01
Leverage & Solvency
Interest Coverage Ratio -0.00M-0.00M-0.09M
Equity Ratio 0.950.890.860.890.89
Times Interest Earned -0.00M-0.00M-0.09M
Valuation
Enterprise Value 3,292.12M3,037.92M1,654.38M1,213.45M565.33M
Market Capitalization 3,739.77M3,318.04M1,806.17M1,357.19M689.62M
Return Ratios
Return on Sales -0.63%-120.13%-210.35%-13.39%-33.75%
Return on Capital Employed -0.41%-0.30%-0.40%-0.46%
Return on Assets -0.40%-0.28%-0.35%-0.39%
Return on Equity -0.44%-0.31%-0.40%-0.44%